1. Home
  2. AUPH vs BOW Comparison

AUPH vs BOW Comparison

Compare AUPH & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AUPH
  • BOW
  • Stock Information
  • Founded
  • AUPH 1993
  • BOW 2020
  • Country
  • AUPH Canada
  • BOW United States
  • Employees
  • AUPH N/A
  • BOW N/A
  • Industry
  • AUPH Biotechnology: Pharmaceutical Preparations
  • BOW Property-Casualty Insurers
  • Sector
  • AUPH Health Care
  • BOW Finance
  • Exchange
  • AUPH Nasdaq
  • BOW Nasdaq
  • Market Cap
  • AUPH 1.3B
  • BOW 1.2B
  • IPO Year
  • AUPH 1999
  • BOW 2024
  • Fundamental
  • Price
  • AUPH $8.01
  • BOW $33.00
  • Analyst Decision
  • AUPH Strong Buy
  • BOW Hold
  • Analyst Count
  • AUPH 3
  • BOW 5
  • Target Price
  • AUPH $10.33
  • BOW $33.60
  • AVG Volume (30 Days)
  • AUPH 1.4M
  • BOW 167.2K
  • Earning Date
  • AUPH 02-13-2025
  • BOW 02-15-2025
  • Dividend Yield
  • AUPH N/A
  • BOW N/A
  • EPS Growth
  • AUPH N/A
  • BOW 130.44
  • EPS
  • AUPH N/A
  • BOW 1.08
  • Revenue
  • AUPH $220,361,000.00
  • BOW $389,135,000.00
  • Revenue This Year
  • AUPH $36.97
  • BOW N/A
  • Revenue Next Year
  • AUPH $16.43
  • BOW $26.70
  • P/E Ratio
  • AUPH N/A
  • BOW $30.56
  • Revenue Growth
  • AUPH 38.72
  • BOW 107.43
  • 52 Week Low
  • AUPH $4.71
  • BOW $22.14
  • 52 Week High
  • AUPH $10.67
  • BOW $37.81
  • Technical
  • Relative Strength Index (RSI)
  • AUPH 40.52
  • BOW N/A
  • Support Level
  • AUPH $7.60
  • BOW N/A
  • Resistance Level
  • AUPH $9.31
  • BOW N/A
  • Average True Range (ATR)
  • AUPH 0.32
  • BOW 0.00
  • MACD
  • AUPH -0.12
  • BOW 0.00
  • Stochastic Oscillator
  • AUPH 27.45
  • BOW 0.00

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

About BOW Bowhead Specialty Holdings Inc. Common Stock

Bowhead Specialty Holdings Inc is engaged in providing specialty P&C products. It is a specialty insurance group that generates revenues by underwriting and offering a variety of specialty insurance products to domestic markets through three distinct underwriting divisions: Casualty, Professional Liability and Healthcare. Casualty specialize in GL coverage for risks in the construction, distribution, heavy manufacturing, real estate and hospitality segments and also consider underwriting risks in a broader range of industries. Key revenue is generated from Casualty segment.

Share on Social Networks: